rs561367199

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_000048.4(ASL):โ€‹c.332G>Aโ€‹(p.Arg111Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,630 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (โ˜…โ˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R111W) has been classified as Likely pathogenic.

Frequency

Genomes: ๐‘“ 0.000013 ( 0 hom., cov: 32)
Exomes ๐‘“: 0.000014 ( 1 hom. )

Consequence

ASL
NM_000048.4 missense

Scores

15
3
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7U:2

Conservation

PhyloP100: 8.78
Variant links:
Genes affected
ASL (HGNC:746): (argininosuccinate lyase) This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.979
PP5
Variant 7-66082920-G-A is Pathogenic according to our data. Variant chr7-66082920-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 288770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ASLNM_000048.4 linkuse as main transcriptc.332G>A p.Arg111Gln missense_variant 5/17 ENST00000304874.14 NP_000039.2 P04424-1A0A024RDL8
ASLNM_001024943.2 linkuse as main transcriptc.332G>A p.Arg111Gln missense_variant 4/16 NP_001020114.1 P04424-1A0A024RDL8
ASLNM_001024944.2 linkuse as main transcriptc.332G>A p.Arg111Gln missense_variant 4/15 NP_001020115.1 P04424-2
ASLNM_001024946.2 linkuse as main transcriptc.332G>A p.Arg111Gln missense_variant 4/15 NP_001020117.1 A0A0S2Z316

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ASLENST00000304874.14 linkuse as main transcriptc.332G>A p.Arg111Gln missense_variant 5/171 NM_000048.4 ENSP00000307188.9 P04424-1

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152048
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000600
AC:
15
AN:
250184
Hom.:
0
AF XY:
0.0000443
AC XY:
6
AN XY:
135564
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000886
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000144
AC:
21
AN:
1461464
Hom.:
1
Cov.:
31
AF XY:
0.00000825
AC XY:
6
AN XY:
727028
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000335
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152166
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000207
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Argininosuccinate lyase deficiency Pathogenic:6Uncertain:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 18, 2024- -
Pathogenic, no assertion criteria providedclinical testingClinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)Apr 01, 2023- -
Likely pathogenic, criteria provided, single submitterresearchAl Jalila Childrenโ€™s Genomics Center, Al Jalila Childrens Speciality HospitalOct 04, 2024PM5,PM2,PM3(moderate),PP1,PM1,PP3 -
Likely pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMar 25, 2024- -
Uncertain significance, flagged submissionclinical testingCounsylAug 23, 2017- -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 111 of the ASL protein (p.Arg111Gln). This variant is present in population databases (rs561367199, gnomAD 0.04%). This missense change has been observed in individual(s) with argininosuccinate lyase deficiency (PMID: 24516753; Invitae). ClinVar contains an entry for this variant (Variation ID: 288770). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASL protein function with a positive predictive value of 95%. This variant disrupts the p.Arg111 amino acid residue in ASL. Other variant(s) that disrupt this residue have been observed in individuals with ASL-related conditions (PMID: 1705937), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 02, 2023Variant summary: ASL c.332G>A (p.Arg111Gln) results in a conservative amino acid change located in the Fumarate lyase, N-terminal domain (IPR022761) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 250184 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in ASL causing Argininosuccinic Aciduria (6e-05 vs 0.0042), allowing no conclusion about variant significance. c.332G>A has been reported in the literature in multiple homozygous individuals affected with Argininosuccinic Aciduria (e.g., Al-Shamsi_2014, Al-Jasmi_2016, Saleh_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26589311, 24516753, 34374989). Four submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments (pathogenic, n = 1; likely pathogenic, n = 1; uncertain significance, n = 2). Additionally, a different missense variant disrupting the same codon, c.331C>T (p.Arg111Trp), has been reported in patients with Argininosuccinic Aciduria (PMIDs: 1705937, 31737040, 33611823) and classified as likely pathogenic by our lab. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1Uncertain:1
Uncertain significance, flagged submissionclinical testingEurofins Ntd Llc (ga)Jun 30, 2016- -
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxApr 15, 2016The R111Q variant has been published in a patient with argininosuccinic aciduria who was homozygous for R111Q and who was diagnosed following an abnormal newborn screening result (Al-Shamsi et al. 2014). The R111Q variant was not observed with any significant frequency in either the 1000 Genomes Project Consortium or in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The R111Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.95
D;.;D;D;.
Eigen
Pathogenic
0.80
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
.;D;D;D;D
M_CAP
Pathogenic
0.98
D
MetaRNN
Pathogenic
0.98
D;D;D;D;D
MetaSVM
Pathogenic
0.98
D
MutationAssessor
Pathogenic
4.5
H;H;H;.;H
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-3.9
D;D;D;D;D
REVEL
Pathogenic
0.98
Sift
Pathogenic
0.0
D;D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D;D
Polyphen
1.0
D;.;D;.;.
Vest4
0.97
MutPred
0.86
Loss of catalytic residue at S112 (P = 0.0064);Loss of catalytic residue at S112 (P = 0.0064);Loss of catalytic residue at S112 (P = 0.0064);.;Loss of catalytic residue at S112 (P = 0.0064);
MVP
0.99
MPC
1.0
ClinPred
1.0
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.97
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs561367199; hg19: chr7-65547907; COSMIC: COSV100509032; COSMIC: COSV100509032; API